• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential heat shock protein localization in chronic lymphocytic leukemia.慢性淋巴细胞白血病中热休克蛋白的差异定位。
J Leukoc Biol. 2010 Mar;87(3):467-76. doi: 10.1189/jlb.0709502. Epub 2009 Dec 10.
2
Increased inducible heat shock protein 72 expression associated with PBMC isolated from patients with haematological tumours.与血液肿瘤患者分离的 PBMC 相关的诱导型热休克蛋白 72 表达增加。
Scand J Clin Lab Invest. 2012 Sep;72(5):380-6. doi: 10.3109/00365513.2012.681683. Epub 2012 May 1.
3
Heat Shock Protein translocation induced by membrane fluidization increases tumor-cell sensitivity to chemotherapeutic drugs.膜流动性诱导的热休克蛋白易位增加肿瘤细胞对化疗药物的敏感性。
Cancer Lett. 2010 Oct 28;296(2):257-67. doi: 10.1016/j.canlet.2010.04.016. Epub 2010 May 11.
4
ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia.ZAP-70是一种新型的条件性热休克蛋白90(Hsp90)客户蛋白:抑制Hsp90会导致ZAP-70降解、细胞凋亡以及慢性淋巴细胞白血病中的信号传导受损。
Blood. 2005 Oct 1;106(7):2506-12. doi: 10.1182/blood-2005-03-1099. Epub 2005 Jun 21.
5
TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病患者白血病细胞上的 TLR2 表达。
Arch Immunol Ther Exp (Warsz). 2019 Feb;67(1):55-65. doi: 10.1007/s00005-018-0523-9. Epub 2018 Sep 8.
6
The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.热休克蛋白27(HSP27)的表达与肝内胆管癌的不良临床预后相关。
BMC Cancer. 2007 Dec 21;7:232. doi: 10.1186/1471-2407-7-232.
7
Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.B 细胞慢性淋巴细胞白血病中 B 细胞上受体 - 配体对的表型分析
Leuk Lymphoma. 1997 Apr;25(3-4):301-11. doi: 10.3109/10428199709114169.
8
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia.α2巨球蛋白在慢性淋巴细胞白血病患者IgG聚集及补体系统慢性激活中的作用
Front Immunol. 2021 Feb 11;11:603569. doi: 10.3389/fimmu.2020.603569. eCollection 2020.
9
Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.单剂量摇头丸给药后黑褐大鼠血清素能轴突损伤及Hsp27、Hsp72和Hsp90分子伴侣的免疫定位:时间、空间和细胞模式
J Comp Neurol. 2006 Jul 10;497(2):251-69. doi: 10.1002/cne.20994.
10
Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.慢性淋巴细胞白血病患者外周血和骨髓中T淋巴细胞和B淋巴细胞表面CD25和CD69的表达与该疾病既定预后因素之间的关系。
Adv Clin Exp Med. 2018 Jul;27(7):987-999. doi: 10.17219/acem/74437.

引用本文的文献

1
Investigating the impact of berberine on autophagy-mediated drug resistance in chronic lymphocytic leukemia tumor cells.研究小檗碱对慢性淋巴细胞白血病肿瘤细胞自噬介导的耐药性的影响。
Med Oncol. 2025 Jun 5;42(7):240. doi: 10.1007/s12032-025-02779-1.
2
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?在血液肿瘤疾病中,HSP70 仍然可以作为治疗靶点吗?
Biomolecules. 2023 Mar 28;13(4):604. doi: 10.3390/biom13040604.
3
Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia.对改变的模块进行系统追踪可识别出慢性淋巴细胞白血病中涉及的关键生物标志物。
Oncol Lett. 2019 Feb;17(2):2351-2355. doi: 10.3892/ol.2018.9812. Epub 2018 Dec 7.
4
Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.靶向热休克因子1破坏慢性淋巴细胞白血病中热休克蛋白90的伴侣功能。
Oncotarget. 2015 Oct 13;6(31):31767-79. doi: 10.18632/oncotarget.5167.
5
HSP90 inhibitors decrease AID levels and activity in mice and in human cells.热休克蛋白90(HSP90)抑制剂可降低小鼠和人类细胞中活化诱导胞嘧啶脱氨酶(AID)的水平及活性。
Eur J Immunol. 2015 Aug;45(8):2365-76. doi: 10.1002/eji.201545462. Epub 2015 May 18.
6
The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.热休克蛋白90抑制剂ganetespib:一种与阿糖胞苷联合用于急性髓系白血病的潜在有效药物。
Leuk Res. 2015 Jun;39(6):617-24. doi: 10.1016/j.leukres.2015.03.016. Epub 2015 Mar 30.
7
Pathology-dependent effects linked to small heat shock proteins expression: an update.与小热休克蛋白表达相关的病理依赖性效应:最新进展
Scientifica (Cairo). 2012;2012:185641. doi: 10.6064/2012/185641. Epub 2012 Oct 9.
8
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.热休克蛋白90抑制剂NVP-AUY922-AG可抑制核因子κB信号传导,克服微环境细胞保护作用,并且在原发性慢性淋巴细胞白血病细胞中与氟达拉滨具有高度协同作用。
Oncotarget. 2012 May;3(5):525-34. doi: 10.18632/oncotarget.491.
9
Frozen tissue can provide reproducible proteomic results of subcellular fractionation.冰冻组织可提供亚细胞组分分离的可重现蛋白质组学结果。
Anal Biochem. 2011 Nov 1;418(1):78-84. doi: 10.1016/j.ab.2011.06.045. Epub 2011 Jul 13.

本文引用的文献

1
Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells.热休克蛋白70与细胞外磷脂酰丝氨酸的结合促进对常氧和低氧肿瘤细胞的杀伤。
FASEB J. 2009 Aug;23(8):2467-77. doi: 10.1096/fj.08-125229. Epub 2009 Mar 16.
2
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.通过CCL22/CCR4募集的调节性T细胞在原发性乳腺肿瘤周围的淋巴浸润中被选择性激活,并导致不良临床结局。
Cancer Res. 2009 Mar 1;69(5):2000-9. doi: 10.1158/0008-5472.CAN-08-2360. Epub 2009 Feb 24.
3
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.免疫抑制性调节性T细胞与侵袭性乳腺癌表型相关:一个潜在的治疗靶点。
Mod Pathol. 2008 Dec;21(12):1527-32. doi: 10.1038/modpathol.2008.160. Epub 2008 Sep 26.
4
Targeting Hsp90 prevents escape of breast cancer cells from tyrosine kinase inhibition.靶向热休克蛋白90可防止乳腺癌细胞逃避酪氨酸激酶抑制作用。
Cell Cycle. 2008 Sep 15;7(18):2936-41. doi: 10.4161/cc.7.18.6701. Epub 2008 Sep 30.
5
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.调节性T细胞可能参与原发性乳腺癌的肿瘤发生和进展。
Cancer Immunol Immunother. 2009 Mar;58(3):441-7. doi: 10.1007/s00262-008-0570-x. Epub 2008 Aug 7.
6
Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex.多发性硬化症患者对糖皮质激素治疗耐药:糖皮质激素受体复合物中热休克蛋白90表达异常。
Mult Scler. 2008 Aug;14(7):919-26. doi: 10.1177/1352458508090666. Epub 2008 Jun 23.
7
Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.白藜芦醇通过靶向一种关键的生存蛋白——热休克蛋白70,诱导K562(慢性粒细胞白血病)细胞凋亡。
Cancer Sci. 2008 Jun;99(6):1109-16. doi: 10.1111/j.1349-7006.2008.00809.x. Epub 2008 Apr 21.
8
The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.肿瘤细胞中热休克蛋白70(Hsp70)表达的临床应用调节剂的治疗意义。
Cell Stress Chaperones. 2008 Spring;13(1):1-10. doi: 10.1007/s12192-007-0006-0. Epub 2008 Feb 5.
9
The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.热休克蛋白27(HSP27)的表达与肝内胆管癌的不良临床预后相关。
BMC Cancer. 2007 Dec 21;7:232. doi: 10.1186/1471-2407-7-232.
10
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.热休克蛋白90(Hsp90)抑制对野生型和突变型p53具有相反的作用,并且在慢性淋巴细胞白血病细胞中,无论p53/ATM状态如何,均可诱导p21表达和细胞毒性。
Oncogene. 2008 Apr 10;27(17):2445-55. doi: 10.1038/sj.onc.1210893. Epub 2007 Nov 5.

慢性淋巴细胞白血病中热休克蛋白的差异定位。

Differential heat shock protein localization in chronic lymphocytic leukemia.

机构信息

Chester Centre for Stress Research, University of Chester, Chester, United Kingdom.

出版信息

J Leukoc Biol. 2010 Mar;87(3):467-76. doi: 10.1189/jlb.0709502. Epub 2009 Dec 10.

DOI:10.1189/jlb.0709502
PMID:20007907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2830125/
Abstract

Mechanisms behind carcinogenesis and resistance of tumor cells to treatment regimes remain elusive. The major stress proteins Hsp72, Hsp90, and Hsp27 are credible candidates to provide this resistance, as their overexpression in many cancer types is well documented. In addition to being present inside tumor cells, where they confer resistance to apoptosis, Hsp72, in particular, is presented externally, embedded in the cell membrane of cancer cells. This study aimed to investigate the localization of Hsp72, Hsp90, and Hsp27 in leukocytes from patients with CLL and age-matched control subjects. CLL patients were found to express significantly higher levels of iHsp90 (CLL=2463 MFI; control=748 MFI) and iHsp27 (CLL=2190 MFI; control=1031 MFI) in lymphocytes than that expressed by lymphocytes from control subjects. Furthermore, expression of iHsp90 was shown to be related to stage of disease, and expression of iHsp27 correlated with levels of active caspase-3. Patients were found to express very high levels or very low levels of sHsp72 and iHsp72 in CD5(+)/CD19(+) cells, although surface and intracellular datasets did not correlate. Levels of extracellular Hsp72 circulating in the serum were found to correlate with internal levels of Hsp72 and were also found to be significantly lower in patients receiving corticosteroid treatment than in patients not receiving corticosteroid treatment. Finally, analysis of the number of circulating Tregs revealed significantly elevated numbers in CLL patients compared with control subjects.

摘要

肿瘤细胞发生癌变和对治疗方案产生耐药性的机制仍难以捉摸。主要的应激蛋白 Hsp72、Hsp90 和 Hsp27 是提供这种耐药性的可信候选者,因为它们在许多癌症类型中的过度表达已有充分记录。除了存在于肿瘤细胞内部,赋予它们抗细胞凋亡的能力之外,Hsp72 特别是嵌入癌细胞的细胞膜中,外部也存在。本研究旨在研究 CLL 患者和年龄匹配的对照组白细胞中 Hsp72、Hsp90 和 Hsp27 的定位。与对照组淋巴细胞相比,CLL 患者的淋巴细胞中 iHsp90(CLL=2463 MFI;对照=748 MFI)和 iHsp27(CLL=2190 MFI;对照=1031 MFI)表达水平显著升高。此外,iHsp90 的表达与疾病分期有关,iHsp27 的表达与活性 caspase-3 水平相关。患者在 CD5(+)/CD19(+)细胞中表达非常高或非常低水平的 sHsp72 和 iHsp72,尽管表面和细胞内数据集不相关。在血清中循环的细胞外 Hsp72 水平与细胞内 Hsp72 水平相关,并且在接受皮质类固醇治疗的患者中明显低于未接受皮质类固醇治疗的患者。最后,对循环 Treg 数量的分析显示,CLL 患者的数量明显高于对照组。